This week we are reading about eHealth’s fourth quarter results, Centene closing its acquisition of Wellcare, and Molina and Centene addressing investors on organic growth.

eHealth, Inc. Announces Preliminary Results for the Fourth Quarter and Fiscal Year 2019 | PR Newswire | January 23, 2020

eHealth, Inc., a leading private online health insurance exchange in the United States, today preliminary, unaudited financial results and select operating metrics for the fourth quarter and fiscal year ended December 31, 2019. Fourth quarter 2019 approved members for all Medicare products grew 88% compared to the fourth quarter of 2018. Fourth quarter 2019 approved members for Medicare Advantage products grew 100% compared to the fourth quarter of 2018.

Read the full press release on here.

Centene closes $17B acquisition of Wellcare | Healthcare Dive | January 23, 2020

Centene said Tuesday it has satisfied all regulatory approvals necessary to complete its $17 billion acquisition of rival WellCare, including review by the U.S. Department of Justice. When the deal is completed, it will include previously announced divestitures of WellCare’s Medicaid plans in Missouri and Nebraska and Medicare Advantage plans in Missouri as well as Centene’s Medicaid and MA plans in Illinois. The deal is expected to close Thursday, according to a statement from Centene CEO Michael Neidorff.

Read the full article on here.

JPM20: Rivals Molina, Centene pitch investors on organic growth | Healthcare Dive | January 14, 2020

The chief executives of two competing managed care firms kicked off the J.P. Morgan Healthcare Conference on Monday addressing a similar theme, arguing the case their company is posed to unlock more long-term organic growth. JPM’s annual conference in San Francisco, one of the industry’s most influential, features some of the nation’s largest nonprofit health systems, pharmaceutical firms and insurers, including rivals Centene and Molina.


The leader of Long Beach, California-based Molina was clear about strategy moving forward. The payer will use its $1.7 billion in excess capital to reinvest in the company, honing in on three areas: organic growth, inorganic growth through bolt-on acquisitions and share repurchasing.

Read the full article on here.